Related Experiment Video
Updated: Mar 18, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
Published on: January 29, 2014
Complement inhibition in C3 glomerulopathy
Carla M Nester1, Richard J H Smith1
1Molecular Otolaryngology and Renal Research Laboratories, Carver College of Medicine, University of Iowa, Iowa City, IA, USA; Divisions of Nephrology, Stead Family Department of Pediatrics, Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
Insights
C3 glomerulopathy (C3G) is a kidney disease characterized by C3 protein deposits. Understanding complement dysregulation is key to developing targeted treatments like complement inhibition.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- C3 glomerulopathy (C3G) is a group of kidney diseases defined by specific renal biopsy findings.
- These findings include predominant C3 complement protein deposition, identifiable via immunofluorescence and electron microscopy.
- Complement system dysregulation is the established cause of C3G, driven by genetic and acquired factors.
Purpose of the Study:
- To provide a comprehensive overview of C3 glomerulopathy (C3G).
- To discuss the definition, pathology, and underlying causes of C3G, focusing on complement dysregulation.
- To review emerging molecular markers and the potential of complement inhibition as a therapeutic strategy.
Main Methods:
- Review of existing literature on C3 glomerulopathy.
- Analysis of pathological features from renal biopsies (immunofluorescence, electron microscopy).
- Discussion of genetic and acquired factors contributing to complement dysregulation.
Main Results:
- C3G is characterized by specific C3 deposition patterns in the glomeruli.
- Complement dysregulation, involving genetic and acquired factors, is causally linked to C3G.
- Biomarkers are enhancing the understanding of C3G pathology.
Conclusions:
- C3G encompasses a spectrum of kidney diseases unified by C3 deposition and complement dysregulation.
- Advances in understanding molecular markers and complement pathways are crucial for C3G.
- Complement inhibition shows promise as a targeted treatment for C3G.
Abstract:
C3 glomerulopathy (C3G) describes a spectrum of glomerular diseases defined by shared renal biopsy pathology: a predominance of C3 deposition on immunofluorescence with electron microscopy permitting disease sub-classification. Complement dysregulation underlies the observed pathology, a causal relationship that is supported by well described studies of genetic and acquired drivers of disease. In this article, we provide an overview of the features of C3G, including a discussion of disease definition and a review of the causal role of complement. We discuss molecular markers of disease and how biomarkers are informing our evolving understanding of underlying pathology. Research advances are laying the foundation for complement inhibition as a targeted approach to treatment of C3G.
Related Concept Videos
Complement System
Hypersensitivity Reactions: Cytolytic Reactions
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Hypersensitivity Reactions: Immune-Complex Reactions
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...

